• June 3-6, 2024
  • San Diego Convention Center, California


Dario Heymann

Dario Heymann, PhD

Chief Growth Officer
Galen Growth
Dario is the Chief Research Offer of Galen Growth where he leads the building and venture analytics of HealthTech Alpha; the most compelling database and analytics platform dedicated to Digital Health ventures. HealthTech Alpha, remains the only database and analytics provider for digital health in the world, delivering accurate and regularly curated information to investors, industry innovation leaders, start-ups CxOs, and researchers. He leads research engagements and leadership alignments with clients, including pharmaceutical companies, insurance companies, investors and tech companies. Besides overseeing and managing the development of the analytic platform, Dario is responsible for the overall research and market intelligence of the HealthTech ecosystem in Asia which helps inform and improve organisations’ overall strategy by grounding decisions in real-world evidence and analysis. Dario helps organisations grow by providing insights and comprehensive sources, vital to monitor the pulse of the ecosystem and accelerate business strategies. Prior to Galen Growth, Dario worked in drug discovery mainly for the development of novel drugs in oncology, both in pharma and academia in Singapore, China and Germany. Dario holds a PhD in Material Science & Engineering where he worked on novel biodegradable materials used for prosthesis, and Masters in Biochemistry and Molecular Biology.
Speaking In


Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.